Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was [...]
House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” [...]